Filing search / Cartesian Therapeutics, Inc. / "Injury"

424B7

RNAC Cartesian Therapeutics, Inc.

1 Oct 24

Prospectus with selling stockholder info

4:36pm

that we may develop; injury to our reputation and significant negative media attention; loss of clinical trial participants or increased difficulty … of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held

8-K

EX-10.2

RNAC Cartesian Therapeutics, Inc.

1 Apr 24

Departure of Directors or Certain Officers

4:32pm

injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits; (d) any and all claims for violation of any

8-K

EX-10.1

0sw8uow 2mxj

1 Apr 24

Departure of Directors or Certain Officers

4:32pm

8-K

EX-99.1

i00msr2vniz2bbr3

18 Nov 22

November 2022 Selecta Biosciences Corporate Presentation SELB

4:30pm

8-K

EX-99.1

im2pxqr70iynn3f3

4 Aug 22

August 2022 Selecta Biosciences Corporate Presentation SELB

8:05am

8-K

EX-99.1

jgf2kcivdi4skkyfb 4l

13 Apr 22

April 2022 Selecta Biosciences Corporate Presentation SELB

7:00am

8-K

EX-99.1

cqjpp7mn

6 Apr 22

Other Events

4:11pm

8-K

EX-99.1

gtamsp23

16 Feb 22

February 2022 Selecta Biosciences Corporate Presentation SELB

8:00am